Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions

Gut

Volumn 56, Issue 5, 2007, Pages 637-644

  Anlauf, M ^a   Perren, A ^b   Henopp, T ^a   Rudolph, T ^b   Garbrecht, N ^a   Schmitt, A ^b   Raffel, A ^c   Gimm, O ^d   Weihe, E ^e   Knoefel, W T ^c   Dralle, H ^d   Heitz, Ph U ^b   Komminoth, P ^f   Kloppel G ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f Kantonsspital Baden   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; SOMATOSTATIN;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DUODENUM TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRINOMA; GENE DELETION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH TUMOR; ZOLLINGER ELLISON SYNDROME;

ADULT; CHROMOSOMES, HUMAN, PAIR 11; DUODENAL NEOPLASMS; FEMALE; GASTRINOMA; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; ZOLLINGER-ELLISON SYNDROME;

EID: 34247498598     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.108910     Document Type: Article

References (31)

1. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990;322:723-7.
2. Pipeleers-Marichal M, Donow C, Heitz PU, et al. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I. World J Surg 1993;17:481-8.
3. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999;341:635-44.
4. Anlauf M, Perren A, Meyer CL, et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 2005;128:1187-98.
5. Calender A, Morrison CD, Komminoth P, et al. Multiple endocrine neoplasia type 1. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and genetic: tumours of endocrine organs. WHO classification of tumors. Lyon: IARC Press, 2004:218-27.
6. Heppner C, Bilimoria KY, Agarwal SK, et al. The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 2001;20:4917-25.
7. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
8. Bystrom C, Larsson C, Blomberg C, et al. Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 1990;87:1968-72.
9. Lubensky IA, Debelenko LV, Zhuang Z, et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 1996;56:5272-8.
10. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-7.
11. Debelenko LV, Zhuang Z, Emmert-Buck MR, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 1997;57:2238-43.
12. Debelenko LV, Emmert-Buck MR, Zhuang Z, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;113:773-81.
13. Dong Q, Debelenko LV, Chandrasekharappa SC, et al. Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997;82:1416-20.
14. Hessman O, Skogseid B, Westin G, et al. Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors. J Clin Endocrinol Metab 2001;86:1355-61.
15. Vortmeyer AO, Huang S, Lubensky I, et al. Non-islet origin of pancreatic islet cell tumors. J Clin Endocrinol Metab 2004;89:1934-8.
16. Barghorn A, Speel EJ, Farspour B, et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression or sporadic endocrine pancreatic tumors. Am J Pathol 2001;158: 1903-11.
17. Speel EJ, Scheidweiler AF, Zhao J, et al. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res 2001;61:5186-92.
18. Chen YJ, Vortmeyer A, Zhuang Z, et al. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance. Cancer Res 2003;63:817-23.
19. Perren A, Saremaslani P, Schmid S, et al. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors. Diagn Mol Pathol 2003;12:181-6.
20. Capella C, Riva C, Rindi G, et al. Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: a study of 44 cases. Endocr Pathol 1991;2:92-110.
21. Burke AP, Federspiel BH, Sobin LH, et al. Carcinoids of the duodenum. A histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989;13:828-37.
22. Stamm B, Hedinger CE, Saremaslani P. Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN 1 syndrome and von Recklingshausen's disease (neurofibromatosis). Virchows Arch [A] Pathol Anat 1986;408:475-89.
23. Anlauf M, Schlenger R, Perren A, et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 2006;30:560-74.
24. Feurle GE, Anlauf M, Hamscher G, et al. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology 2002;123:1616-26.
25. Sipos B, Weber D, Ungefroren H, et al. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Int J Cancer 2002;102:592-600.
26. Oberholzer M, Heitz PU, Klöppel G, et al. Morphometry in endocrine pathology. Pathol Res Pract 1984;179:220-4.
27. Anlauf M, Wieben D, Perren A, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence and characterization of β-cell changes. Am J Surg Pathol 2005;29:524-33.
28. Pannett AA, Thakker RV. Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. J Clin Endocrinol Metab 2001;86:4371-4.
29. Klöppel G, Willemer S, Stamm B, et al. An immunocytochemical study of nine patients. Cancer 1986;57:1824-32.
30. Thompson NW, Lloyd RV, Nishiyama RH, et al. MEN 1 pancreas: a histological and immunohislochemical study. World J Surg 1984;8:561-74.
31. Le Bodic MF, Heymann MF, Lecomte M, et al. Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I. Am J Surg Pathol 1996;20:1378-84.